(Q57019193)

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Definition, function and pathophysiological significance of chemokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

AF12198, a novel low molecular weight antagonist, selectively binds the human type I interleukin (IL)-1 receptor and blocks in vivo responses to IL-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns].

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Discovery of a novel, potent, and orally active nonpeptide antagonist of the human luteinizing hormone-releasing hormone (LHRH) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Synthesis, corticotropin-releasing factor receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and -pyridines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Chemokine receptors and HIV-1: the fusion of two major research fields

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Virus proteins that bind cytokines, chemokines or interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Role of the myxoma virus soluble CC-chemokine inhibitor glycoprotein, M-T1, during myxoma virus pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Identification of a glycosaminoglycan binding surface on human interleukin-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Chemokine antagonists that discriminate between interleukin-8 receptors. Selective blockers of CXCR2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

RANTES and MCP-3 antagonists bind multiple chemokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Antagonists of monocyte chemoattractant protein 1 identified by modification of functionally critical NH2-terminal residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

CD26-processed RANTES(3-68), but not intact RANTES, has potent anti-HIV-1 activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Extension of recombinant human RANTES by the retention of the initiating methionine produces a potent antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Synthesis and evaluation of fluorescent chemokines labeled at the amino terminal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

A fluorescent interleukin-8 receptor probe produced by targetted labelling at the amino terminus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Receptor-mediated endocytosis of CC-chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Plagiarism of the host immune system: lessons about chemokine immunology from viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

The molecular mechanism of B cell activation by toll-like receptor protein RP-105

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Identification and characterization of small molecule functional antagonists of the CCR1 chemokine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

Opportunities for novel therapeutic agents acting at chemokine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.9.11.1471